{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-25-000029","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.579059+00:00","generated_at":"2026-05-17T18:43:01.256201+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ICU Medical Q2 revenue down 8% to $549M, but GAAP net income of $35.3M vs year-ago loss","bullets":["Revenue $548.9M vs $596.5M YoY; GAAP gross margin improved to 38% from 35%.","GAAP net income $35.3M ($1.43 diluted EPS) vs net loss of $(21.4M) ($(0.88) EPS) in Q2 2024.","Adjusted diluted EPS $2.10 vs $1.56 YoY; Adjusted EBITDA $100.3M vs $91.3M.","Fiscal 2025 guidance updated in the press release; specifics not provided in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-25-000029","json":"https://secwatch.observer/filing/0000883984-25-000029.json","markdown":"https://secwatch.observer/filing/0000883984-25-000029.md","text":"https://secwatch.observer/filing/0000883984-25-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/0000883984-25-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/icui-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:43:01.256201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}